REPLAY | Lumos Diagnostics Q3 FY26 Investor Briefing
21 April 2026
Lumos Diagnostics recently hosted an investor webinar covering its Q3 FY26 financial results and operational progress.
In this session, Lumos Chairman Sam Lanyon, CEO Doug Ward and CFO Barrie Lambert provided an update on the early US rollout activity following CLIA waiver, as well as broader operational developments.
In this session, Lumos Chairman Sam Lanyon, CEO Doug Ward and CFO Barrie Lambert provided an update on the early US rollout activity following CLIA waiver, as well as broader operational developments.
